Scarica l'app Stockscreener
44.04
0.02%
0.010
Dopo l'orario di chiusura:
44.04
Precedente Chiudi:
$44.03
Aprire:
$43.46
Volume 24 ore:
446.15K
Relative Volume:
0.62
Capitalizzazione di mercato:
$1.54B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.85%
1M Prestazione:
+28.14%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$42.41
$45.35
Intervallo di 1 settimana:
$42.41
$49.91
Portata 52W:
$14.72
$49.91
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Nome
First Tracks Biotherapeutics Inc
Settore
Industria
Telefono
212-373-3000
Indirizzo
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
44.04 | 1.61B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Iniziato | Leerink Partners | Outperform |
| 2026-04-24 | Iniziato | Wedbush | Outperform |
| 2026-04-23 | Iniziato | JP Morgan | Overweight |
| 2026-04-22 | Iniziato | Barclays | Overweight |
| 2026-04-21 | Iniziato | UBS | Buy |
First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie
AnaptysBio earnings ahead: First results as royalty company By Investing.com - Investing.com Australia
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
First Tracks Biotherapeutics (NASDAQ: TRAX) Share Price, TRAX Stock News, TRAX Share Price & Updates - kalkine.ca
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $63.38, Implies 37% Upside - TradingView
Piper Sandler raises First Tracks stock price target on pipeline progress - Investing.com Australia
TRAX Maintained by First Tracks -- Price Target Raised to $95.00 - GuruFocus
First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results - Benzinga
A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95 - moomoo.com
TRAX Maintained by HC Wainwright & Co. -- Price Target Raised to $57.00 - GuruFocus
Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating - marketscreener.com
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $60.5, Implies 31% Upside - tradingview.com
TRAX SWOT Analysis: Clinical Pipeline and Financial Challenges R - GuruFocus
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:13 AM - Bitget
Form 8K FIRST TRACKS BIOTHERAPEUTICS For: 12 August By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics 2Q 2026: Net loss $(33.4M), EPS $(0.95) — 10-Q Summary - TradingView
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
First Tracks Biotherapeutics (TRAX) details $83.9M loss and $168M cash after spin-off - Stock Titan
symbol__ Stock Quote Price and Forecast - cnn.com
First Tracks Biotherapeutics Ord Shs (TRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMR LLC Acquires Stake in First Tracks Biotherapeutics Inc (TRAX): A Strategic Bet on Clinical-Stage Innovation - GuruFocus
UBS Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65 - moomoo.com
UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating - moomoo.com
First Tracks Biotherapeutics (TRAX) reports 16,667 performance stock units - Stock Titan
AnaptysBio earnings ahead: Can royalty revenue offset spinoff volatility? - Investing.com
AnaptysBio earnings ahead: Can royalty revenue offset spinoff volatility? By Investing.com - Investing.com Canada
First Tracks Biotherapeutics (TRAX) awards 60,492 performance stock units - Stock Titan
First Tracks Biotherapeutics (TRAX) awards 60,492 PSUs to CMO - Stock Titan
Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR - RTTNews
First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo - The Globe and Mail
Wells Fargo Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $55 - Moomoo
First Tracks Is Maintained at Overweight by Wells Fargo - moomoo.com
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential - TipRanks
After Forte acquisition, H.C. Wainwright says First Tracks could be target - TipRanks
TRAX Stock Volatile As Traders Focus On Cash And Momentum - StocksToTrade
Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating - marketscreener.com
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
These stocks that are showing activity before the opening bell on Monday. - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anaptysbio, Inc Net Worth (2026) - GuruFocus
Which stocks are moving before the opening bell on Thursday? - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $54 - Moomoo
TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Stocktwits
First Tracks Biotherapeutics (TRAX) Stock Forum and Discussion - Moomoo
First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
First Tracks Biotherapeutics (TRAX) News Flow - Moomoo
Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX) - The Globe and Mail
XPEV Stock Rises 1.5% As CEO Takes First Robotaxi Ride In Guangzhou - Stocktwits
Meta, Moderna among market cap stock movers on Friday By Investing.com - Investing.com Australia
TRAX Stock Surges As Traders Pile Into Biotech Momentum - timothysykes.com
Lithium Americas Corp. (LAC) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
First Tracks Biotherapeutics Inc Azioni (TRAX) Dati Finanziari
Non sono disponibili dati finanziari per First Tracks Biotherapeutics Inc (TRAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):